Fierce Healthcare

Tempus Picks Up CRO Highline Sciences as the Precision Medicine Company Expands Its Healthcare Ambitions

Feb 08, 2022
AI
Clinical Trials
Data
Oncology
Media Coverage

Related content

A Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 Years

2025-05-28
Oncology

Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium

2024-12-10
Oncology

Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024

2024-09-13
Oncology